Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.52 EUR | 0.00% | +1.43% | -2.85% |
Apr. 30 | Emak best performer; Bialetti trailing. | AN |
Apr. 02 | Fine Foods narrows loss in 2023; up 22 percent in revenue | AN |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company is not the most generous with respect to shareholders' compensation.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.85% | 225M | A- | ||
+13.21% | 8.15B | D+ | ||
+3.16% | 7.52B | C- | ||
+12.30% | 6.65B | - | ||
-5.71% | 3.73B | B- | ||
-6.99% | 3.72B | D | ||
-4.78% | 1.31B | - | - | |
+12.61% | 972M | - | ||
-37.22% | 958M | B+ | ||
-15.02% | 876M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- FF Stock
- Ratings Fine Foods & Pharmaceuticals N.T.M. S.p.A.